Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 7;10(4):e0122246.
doi: 10.1371/journal.pone.0122246. eCollection 2015.

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process

Barbara Farrell  1 , Corey Tsang  2 , Lalitha Raman-Wilms  3 , Hannah Irving  4 , James Conklin  5 , Kevin Pottie  6
Affiliations

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process

Barbara Farrell et al. PLoS One. .

Abstract

Polypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (≥ 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Example histogram showing overall first round and personal results.
Fig 2
Fig 2. Participant flow diagram through three rounds of the Delphi consensus process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344: e3502 10.1136/bmj.e3502 - DOI - PubMed
    1. Heath I. Overdiagnosis: when good intentions meet vested interests—an essay by Iona Heath. BMJ. 2013;347: f6361 10.1136/bmj.f6361 - DOI - PubMed
    1. Welch GH, Schwartz LM, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston: Beacon Press; 2011.
    1. Godlee F. Preventing overdiagnosis. BMJ. 2012;344: e3783 10.1136/bmj.e3783 - DOI
    1. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5: 345–51. 10.1016/j.amjopharm.2007.12.002 - DOI - PubMed

Publication types

Grants and funding

This study was funded by the Ontario Ministry of Health and Long-Term Care (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BF is the principal investigator; JC is the co-principal investigator.

LinkOut - more resources